The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death
Abstract Background The mortality of castration‐resistant prostate cancer (CRPC) is high due to lack of an effective treatment. Chimeric antigen receptor (CAR)‐based therapy is a promising immunotherapeutic strategy. Here, we aimed to design a novel CAR‐natural killer (NK) cells with a clinically si...
Main Authors: | Liyuan Wu, Fei Liu, Le Yin, Fangming Wang, Hui Shi, Qinxin Zhao, Feiya Yang, Dong Chen, Xiying Dong, Yuchun Gu, Nianzeng Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | Cancer Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/cac2.12321 |
Similar Items
-
Utilizing chimeric antigen receptors to direct natural killer cell activity
by: Dan S Kaufman, et al.
Published: (2015-04-01) -
Chimeric antigen receptor T-cell therapy for T-ALL and AML
by: Wenwen Wei, et al.
Published: (2022-11-01) -
Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting
by: Stefan Grote, et al.
Published: (2020-01-01) -
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
by: Olaf Oberschmidt, et al.
Published: (2017-06-01) -
Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases
by: Stefan Grote, et al.
Published: (2021-03-01)